We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Minimizing Blood Flow Interruption During Surgery Lowers Kidney Disease Risk

By HospiMedica International staff writers
Posted on 30 Jun 2010
Interrupting blood flow for more than 20 to 25 minutes during kidney cancer surgery leads to a greater risk for patients developing chronic kidney disease, according to a new study.

Researchers at the Mayo Clinic (Rochester, MD, USA) and the Cleveland Clinic (OH, USA) analyzed the outcomes of 362 patients (median age 62 years) with only one kidney who underwent surgery for renal cortical tumors at the Mayo Clinic and Cleveland Clinic between 1990 and 2008. More...
The surgeons used a technique called warm ischemia, which involves cutting off the blood supply to the kidney with clamps in order to control bleeding and to keep blood from obscuring the surgeon's view of the kidney; the ischemia is warm as the patient's kidneys are maintained at body temperature during the partial nephrectomy.

The researcher reported that the median ischemia time was 21 minutes; each additional minute of warm ischemia was associated with a 5-6% increase in the odds of developing acute renal failure or reduced kidney functioning, and was associated with a 6% increased risk of new onset Stage IV chronic kidney disease during long-term follow-up. The researchers stressed that the study's results do not have implications for patients treated with cold ischemia.

"These results suggest that every minute counts when the renal arteries and veins are clamped,” said lead author urologist R. Houston Thompson, M.D., of the Mayo Clinic. "When planning for the surgery, surgeons should make efforts to minimize ischemia time, especially in situations where a person only has one kidney.”

"Historically, 30 minutes was considered the maximum safe duration of warm ischemia during partial nephrectomy, and other retrospective clinical studies have suggested that warm ischemia for 40 to 55 minutes is safe,” added Dr. Thompson. "However, these studies included patients with two kidneys, which could mask the true effects of ischemia on renal function. Because each additional minute of warm ischemia invites the risk for chronic kidney problems, if longer ischemic times are unavoidable, techniques such as ice slush (cold ischemia) should be considered.”

Related Links:
Mayo Clinic
Cleveland Clinic



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.